Abstract
e15129 Background: The combination of gemcitabine (G) and cisplatin (C) is considered the standard of care in inoperable BTC based on the ABC-02 trial that showed an increased median progression fr...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
